SGLT2 inhibitor: Difference between revisions
Created page with "{{Drug List/ja|state6=uncollapsed}} {{Pathnav|Medication|Diabetes medication|frame=1}} {| class="wikitable sortable" style="width:100%" |- !一般名 !先発名 !class="unsortable"| 日本 !創薬/開発 !備考 |- |イプラグリフロジン |[https://amn.astellas.jp/di/detail/sgl/index_sgl-25 スーグラ](Sugulat) ([https://amn.astellas.jp/common/pdfviewer.html/content/dam/jp/amn/jp/ja/di/doc/Pdfs/DocNo202211124_y.pdf PI]) ([https://amn.astellas.jp/common/pdfviewer.html/con..." |
No edit summary |
||
| Line 1: | Line 1: | ||
<languages /> | |||
<translate> | |||
{{Drug List/ja|state6=uncollapsed}} | {{Drug List/ja|state6=uncollapsed}} | ||
{{Pathnav|Medication|Diabetes medication|frame=1}} | {{Pathnav|Medication|Diabetes medication|frame=1}} | ||
| Line 170: | Line 172: | ||
[[Category:SGLT2 inhibitors| ]] | [[Category:SGLT2 inhibitors| ]] | ||
[[Category:Anti-diabetic drugs]] | [[Category:Anti-diabetic drugs]] | ||
</translate> | |||